Open AccessRandomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions
Author(s) -
Jean Fajadet,
William Wijns,
GertJan Laarman,
KarlHeinz Kück,
John A. Ormiston,
Thomas Münzel,
Jeffrey J. Popma,
Peter J. Fitzgerald,
Raoul Bonan,
Richard E. Kuntz
Publication year - 2006
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.591206
Subject(s) - medicine , zotarolimus , restenosis , stent , bare metal stent , target lesion , drug eluting stent , stenosis , surgery , revascularization , radiology , myocardial infarction , cardiology , percutaneous coronary intervention
The use of the Endeavor stent might reduce restenosis and stent thrombosis at 9 months.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom